Angiotensin mutation risk factor for coronary events in black patients

被引：0
|
作者：
不详
机构：
来源：
FUTURE CARDIOLOGY | 2006年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：625 / 625
页数：1
相关论文
共 50 条
  • [31] Predictive risk factors for coronary events in renal transplant patients
    Holdaas, H
    Fellstroem, B
    Jardine, A
    Cole, E
    Nyberg, G
    Gronhagen-Riska, C
    Madsen, S
    Neumayer, HH
    Maes, B
    Ambuhl, P
    Olsson, A
    Holme, I
    Fauchald, P
    Pedersen, T
    Logan, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 503A - 504A
  • [32] Endothelium dysfunction is the risk factor for cardiovascular events in metabolic syndrome patients without evidence of coronary heart disease
    Vikentyev, V. V.
    Polikina, O. A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 659 - 659
  • [33] Slightly increased creatinine level as a risk factor of cardiovascular events in hypertensive patients with coronary artery disease.
    Dzielinska, Z.
    Januszewicz, A.
    Prejbisz, A.
    Kadziela, J.
    Makowiecka-Ciesla, M.
    Tyczynski, P.
    Demkow, M.
    Florczak, E.
    Mielniczuk, R.
    Januszewicz, M.
    Ruzyllo, W.
    JOURNAL OF HYPERTENSION, 2006, 24 : S99 - S99
  • [34] High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients
    Corsetti, JP
    Rainwater, DL
    Moss, AJ
    Zareba, W
    Sparks, CE
    CLINICAL CHEMISTRY, 2006, 52 (07) : 1331 - 1338
  • [35] Angiotensin II is a risk factor for vasospasm after coronary artery bypass grafting in patients with diabetes mellitus, but not in patients without diabetes mellitus
    Shiba, Tatsuo
    Gamoh, Shuji
    Tanaka-Totoribe, Naoko
    Yokota, Atsuko
    Kuwabara, Masachika
    Hisa, Hiroaki
    Yamamoto, Ryuichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S203 - S203
  • [36] Unfavourable risk factor control after coronary events in routine clinical practice
    Elise Sverre
    Kari Peersen
    Einar Husebye
    Erik Gjertsen
    Lars Gullestad
    Torbjørn Moum
    Jan Erik Otterstad
    Toril Dammen
    John Munkhaugen
    BMC Cardiovascular Disorders, 17
  • [37] Unfavourable risk factor control after coronary events in routine clinical practice
    Sverre, Elise
    Peersen, Kari
    Husebye, Einar
    Gjertsen, Erik
    Gullestad, Lars
    Moum, Torbjorn
    Otterstad, Jan Erik
    Dammen, Toril
    Munkhaugen, John
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [38] RISK FACTOR ANALYSIS FOR PATIENTS WITH SLOW CORONARY FLOW
    Katsnelson, M.
    Bhalja, M.
    Diez, J.
    CARDIOLOGY, 2018, 140 : 233 - 233
  • [39] Risk factor awareness in patients with coronary artery disease
    Zimmerli, L.
    Merz, K.
    Hoffmann, A.
    Battegay, E.
    JOURNAL OF HYPERTENSION, 2007, 25 : S356 - S356
  • [40] ASPIRIN RESISTANCE IS A RISK FACTOR FOR NON-FATAL CORONARY EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
    Catakoglu, A. B.
    Aytekin, S.
    Celebi, H.
    Sener, M.
    Kurtoglu, H.
    Demiroglu, I. C. C.
    Aytekin, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 3 - 3
12345